Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 32285 [2021-12767]

Download as PDF Federal Register / Vol. 86, No. 115 / Thursday, June 17, 2021 / Notices partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act. FOR FURTHER INFORMATION CONTACT: Written objections relating to the prospective license or requests for further information may be submitted to Agency Counsel for Intellectual Property, NASA Headquarters at Email: hq-patentoffice@mail.nasa.gov. Questions may be directed to Helen Galus at (202) 358–3437. SUPPLEMENTARY INFORMATION: NASA intends to grant an exclusive, coexclusive, or partially exclusive patent license in the United States to practice the inventions described and claimed in: US 8,735,116 B2, High-Density Spot Seeding for Tissue Model Formation and US 9,243,223 B2, High-Density Spot Seeding for Tissue Model Formation to BSK Health Partners, LLC. having its principal place of business in North Richland Hills, Texas. The fields of use may be limited. NASA has not yet made a final determination to grant the requested license and may deny the requested license even if no objections are submitted within the comment period. This notice of intent to grant an exclusive, co-exclusive or partially exclusive patent license is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective license will comply with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Information about other NASA inventions available for licensing can be found online at http:// technology.nasa.gov. Helen M. Galus, Agency Counsel for Intellectual Property. BILLING CODE 7510–13–P NUCLEAR REGULATORY COMMISSION lotter on DSK11XQN23PROD with NOTICES1 Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a public teleconference meeting of the VerDate Sep<11>2014 18:41 Jun 16, 2021 Jkt 253001 The teleconference meeting will be held on Thursday, July 15, 2021, 1:00 p.m. to 3:00 p.m. Eastern Daylight Time. DATES: Date Webinar information July 15, 2021 .... Link: https:// usnrc.webex.com. Event number: 199 085 4780. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2021.html on or about August 31, 2021. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Jamerson of their planned participation. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in 10 CFR part 7. Dated at Rockville, Maryland this 14th day of June, 2021. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2021–12767 Filed 6–16–21; 8:45 am] BILLING CODE 7590–01–P Public Participation: The meeting will also be held as a webinar. Any member of the public who wishes to participate in any portion of this meeting should register in advance of the meeting by accessing the provided link and event number above. Upon successful registration, an email confirmation will be generated providing the telephone bridge line and a link to join the webinar on the day of the meeting. Members of the public should also monitor the NRC’s Public Meeting Schedule at https://www.nrc.gov/pmns/ mtg for any meeting updates. If there are any questions regarding the meeting, please contact Ms. Jamerson using the information below. Contact Information: Kellee Jamerson, email: Kellee.Jamerson@nrc.gov, telephone: 301–415–7408. Conduct of the Meeting [FR Doc. 2021–12756 Filed 6–16–21; 8:45 am] SUMMARY: Advisory Committee on the Medical Uses of Isotopes (ACMUI) on July 15, 2021, to discuss the ACMUI Subcommittee on Extravasations and Medical Event Reporting draft report on the NRC staff’s preliminary evaluation of whether extravasations merits a change in medical event reporting. The meeting agenda is subject to change. Meeting information, including a copy of the agenda and related documents, will be available on the ACMUI’s Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/ doc-collections/acmui/meetings/ 2021.html. The agenda and related meeting documents may also be obtained by contacting Ms. Kellee Jamerson using the information below. 32285 The ACMUI Chair, Darlene F. Metter, M.D., will preside over the meeting. Dr. Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson at the contact information listed above. All written statements must be received by July 12, 2021, three business days prior to the meeting, and must pertain to the topics on the agenda for the meeting. PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 NUCLEAR REGULATORY COMMISSION [Docket No. 40–8907; NRC–2019–0026] United Nuclear Corporation Church Rock Project Nuclear Regulatory Commission. ACTION: Draft environmental impact statement; reopening of comment period. AGENCY: On November 13, 2020, the U.S. Nuclear Regulatory Commission (NRC) issued for public comment a draft Environmental Impact Statement (EIS) for United Nuclear Corporation’s (UNC) license amendment request. The public comment period closed on May 27, 2021. The NRC has decided to re-open the public comment period to allow more time for members of the public to develop and submit their comments. UNC is requesting authorization to amend its license (SUA–1475) to excavate approximately 1 million cubic yards (CY) of mine waste from the Northeast Church Rock Mine Site and dispose of it at the existing mill site in McKinley County, New Mexico. The NRC plans to hold a public meeting in the future to promote full understanding of the contemplated action and facilitate public comment. DATES: The comment period for the document published on November 13, SUMMARY: E:\FR\FM\17JNN1.SGM 17JNN1

Agencies

[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Notices]
[Page 32285]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12767]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
public teleconference meeting of the Advisory Committee on the Medical 
Uses of Isotopes (ACMUI) on July 15, 2021, to discuss the ACMUI 
Subcommittee on Extravasations and Medical Event Reporting draft report 
on the NRC staff's preliminary evaluation of whether extravasations 
merits a change in medical event reporting. The meeting agenda is 
subject to change. Meeting information, including a copy of the agenda 
and related documents, will be available on the ACMUI's Meetings and 
Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html. The agenda and related meeting 
documents may also be obtained by contacting Ms. Kellee Jamerson using 
the information below.

DATES: The teleconference meeting will be held on Thursday, July 15, 
2021, 1:00 p.m. to 3:00 p.m. Eastern Daylight Time.

------------------------------------------------------------------------
                 Date                          Webinar information
------------------------------------------------------------------------
July 15, 2021.........................  Link: https://usnrc.webex.com.
                                        Event number: 199 085 4780.
------------------------------------------------------------------------

    Public Participation: The meeting will also be held as a webinar. 
Any member of the public who wishes to participate in any portion of 
this meeting should register in advance of the meeting by accessing the 
provided link and event number above. Upon successful registration, an 
email confirmation will be generated providing the telephone bridge 
line and a link to join the webinar on the day of the meeting. Members 
of the public should also monitor the NRC's Public Meeting Schedule at 
https://www.nrc.gov/pmns/mtg for any meeting updates. If there are any 
questions regarding the meeting, please contact Ms. Jamerson using the 
information below.
    Contact Information: Kellee Jamerson, email: 
[email protected], telephone: 301-415-7408.

Conduct of the Meeting

    The ACMUI Chair, Darlene F. Metter, M.D., will preside over the 
meeting. Dr. Metter will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson at the contact information listed 
above. All written statements must be received by July 12, 2021, three 
business days prior to the meeting, and must pertain to the topics on 
the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the ACMUI Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html on or about August 31, 2021.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Jamerson of their planned 
participation.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated at Rockville, Maryland this 14th day of June, 2021.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-12767 Filed 6-16-21; 8:45 am]
BILLING CODE 7590-01-P